Cue Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.4M | $45.4M | $20.8M |
| FY2019 | $17.0M | $71.6M | $44.3M |
| FY2020 | $20.6M | $99.5M | $74.9M |
| FY2021 | $17.9M | $83.4M | $64.4M |
| FY2022 | $25.6M | $91.3M | $51.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $11.4M | $45.4M | $20.8M |
| FY2019 | $17.0M | $71.6M | $44.3M |
| FY2020 | $20.6M | $99.5M | $74.9M |
| FY2021 | $17.9M | $83.4M | $64.4M |
| FY2022 | $25.6M | $91.3M | $51.6M |